Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2012
12/13/2012CA2837840A1 Protein-polymer-drug conjugates
12/12/2012EP2532673A2 Tubulysine derivatives
12/12/2012CN102822192A Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
12/12/2012CN102816204A Preparation process of aspartame
12/12/2012CN102816203A Substituted quinoline compound, and preparation method, medicine combination and application thereof
12/12/2012CN101906136B Amino acid-(3,4-dyhydroxy-Phe)-Ser-Leu false peptide, and synthesizing method and application thereof
12/12/2012CN101772507B Proteasome inhibitors
12/12/2012CN101747226B N-oxalic acid acyl amino acid derivatives and N-oxalic acid acyl dipeptide derivatives as well as applications thereof in preparation of consciousness-promoted drugs
12/11/2012US8329946 Histone deacetylases, and uses related thereto
12/11/2012US8329945 Histone deacetylases, and uses related thereto
12/11/2012US8329866 Long acting VEGF inhibitors and methods of use
12/11/2012US8329865 Antimicrobially active peptides
12/11/2012US8329864 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329640 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases
12/11/2012US8329435 Methods for improved uptake of biological molecules
12/11/2012CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/06/2012WO2012166810A1 Biologically active tri-peptide
12/06/2012WO2012165546A1 Method for producing peptide
12/06/2012WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012US20120309944 Growth Hormones With Prolonged In-Vivo Efficacy
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309692 Activation of Peptide Prodrugs by hK2
12/06/2012US20120309690 Prostaglandin-f2 alpha receptor modulators and uses thereof
12/06/2012US20120309674 Pseudodipeptides as mmp inhibitors
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/05/2012EP2528934A1 Aromatic-cationic peptides and uses of same
12/05/2012CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same
12/05/2012CN102807607A Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
12/05/2012CN102807602A Peptide and composition thereof for improving liver dysfunction
12/05/2012CN102807601A Aminoacyl-tryptophanyl-5-methoxytryptamine and preparation method and application thereof
12/05/2012CN102807600A Amino acid modified spinacin derivative and preparation method and application thereof
12/04/2012US8324347 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
12/04/2012US8324346 Bioactive keratin peptides
12/04/2012US8324344 Membrane transduction peptides and methods of delivering material to a target cell
12/04/2012US8324174 Compounds for enzyme inhibition
12/04/2012US8323964 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
12/04/2012US8323918 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
12/04/2012US8323657 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm
12/04/2012CA2544886C Method of removing transition metals from reaction solutions comprising transition metal byproducts
12/04/2012CA2526989C Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
11/2012
11/29/2012WO2012161497A2 Peptide derivatives having a superior moisturizing effect and uses thereof
11/29/2012WO2012160798A1 Glutathione alkylester isotopologue and method for detecting reactive metabolite
11/29/2012US20120302510 Histone deacetylases, and uses related thereto
11/29/2012US20120301918 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester
11/29/2012US20120301490 Immunoconjugates, compositions for making them, and methods of making and use
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/28/2012EP2526942A2 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
11/28/2012EP2526116A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen
11/28/2012CN102803567A Process for production of reduced glutathione
11/28/2012CN102796171A Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796170A Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796169A Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796168A Compounds with thrombolytic activity and preparation method and application thereof
11/28/2012CN102796167A (S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-L-prolyl-L-alanyl-L-amino acid, and preparation method and application thereof
11/28/2012CN102796166A Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof
11/28/2012CN102796165A Arg-Tyr modified aliphatic amine/ alcohol derivatives and preparation method and application thereof
11/28/2012CN102796164A Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof
11/28/2012CN101880314B Bursin-like peptide of gene engineering as well as expression gene and application thereof
11/28/2012CN101602791B Integrin receptor target lipidosome drug carrier, preparation method and application thereof
11/28/2012CN101139625B Ace inhibitory peptides from plant materials
11/27/2012US8318659 Peptide-based organic sunscreens
11/27/2012US8318491 Method of differentiating hematopoietic stem cells into natural killer cells using YC-1 or IL-21
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012US20120295841 Sanglifehrin Based Compounds
11/22/2012US20120295304 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester
11/22/2012US20120294843 Caspase inhibitors
11/21/2012EP2524925A1 Lanthionine derivative
11/21/2012CN202538414U Aspartame crystallization device
11/21/2012CN102787154A Preparation method of black-bone chicken oligopeptide and separation and identification method of active peptide fragment
11/21/2012CN102786580A Antihypertensive active peptide IVP
11/21/2012CN102786579A Antihypertensive active peptide VIP
11/21/2012CN102784383A Methods for preventing mitochondrial permeability transition
11/21/2012CN102408468B Argatroban compound and preparation method thereof
11/21/2012CN102030817B Peptide for inhibiting angiontensin converting enzyme
11/20/2012US8314208 Microwave enhanced N-fmoc deprotection in peptide synthesis
11/20/2012US8314141 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/15/2012WO2012155124A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012US20120289461 Protein synthesis promoter
11/15/2012US20120289455 Monocarbams
11/15/2012US20120289454 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/14/2012EP2521732A2 Serine hydrolase formulation
11/14/2012EP2521731A1 Compounds with both analgesic and anti-hyperalgesic efficacy
11/14/2012CN1505685B Methods for rapid detection and identification of bioagents for environmental testing
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN102775468A Method for selfassembling oligopeptides into different structures on different interfaces
11/14/2012CN102775467A Method for self-assembling self-assembly oligo-peptide into different structures under ultraviolet radiation
11/14/2012CN101238142B Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
11/13/2012US8309685 HCV protease inhibitors and uses thereof
11/13/2012US8309302 Reagents and methods for processing biological samples
11/13/2012CA2615896C Macrocyclic peptides as hcv ns3 protease inhibitors
11/13/2012CA2487061C Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
11/08/2012WO2012151195A1 Hepatitis c virus inhibitors
11/08/2012WO2012047354A4 Environmentally sensitive compositions
11/08/2012US20120283178 Learning motivation improvers
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012CA2835105A1 Hepatitis c virus inhibitors
11/07/2012EP2520180A1 Flavor-enriching agent
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 307